This analysis reveals the effectiveness of physostigmine and rivastigmine against post-injection delirium in patients receiving olanzapine, suggesting improved management strategies.
Introduction Post-injection delirium/sedation syndrome is a rare but serious adverse effect of depot olanzapine, typically managed with supportive care and benzodiazepines.
No takes yet. Share an insight, caveat, or question.
Fotheringham et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: